57.30MMarket Cap-2031P/E (TTM)
1.988High1.875Low118.39KVolume1.920Open1.925Pre Close226.59KTurnover0.59%Turnover RatioLossP/E (Static)30.00MShares5.07052wk High2.07P/B38.19MFloat Cap1.03052wk Low--Dividend TTM19.99MShs Float39.390Historical High--Div YieldTTM5.89%Amplitude1.030Historical Low1.913Avg Price1Lot Size
Neuronetics Stock Forum
Neuronetics: Aetna Updated Tms Coverage to Include Adolescents Aged 15 and Older With
NeuroStar Showcases Cutting-Edge Research at Clinical TMS Society Annual Meeting
Neuronetics announced its participation in the 12th Annual Clinical TMS Society (CTMSS) Meeting in London from June 13-15, 2024. They will present six posters and one oral presentation showcasing data from the NeuroStar TMS System. Highlights include early prediction of nonresponse in major depressive disorder, the impact of treatment timing, efficacy of accelerated TMS protocols, effect...
NEWS
New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital
Neuronetics, Inc. (NASDAQ: STIM) announces significant clinical findings in Brain Stimulation journal regarding the predictive value of early symptom improvement in major depressive disorder (MDD) patients undergoing transcranial magnetic stimulation (TMS) treatment. Lack of early improvement does not predict final non-response status, emphasizing the importance of completing the full 36-...
Dow Jones· just
No comment yet